Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin versus Lucentis for persistent diabetic macular edema or persistent neovascularization after laser photocoagulation
2008-001469-28Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2009
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic macular edema (DME) and diabetic retinopathy (DR) comparing Intravitreal Avastin with Intravitreal Lucentis (2 arms). Primary endpoints: Visual acuity change, Central retinal thickness and 2 more. Started Jan 2009; status: completed.
02
Drugs
bevacizumabranibizumab
03
Conditions
diabetic macular edema (DME)diabetic retinopathy (DR)
Beyond the preview
Go deeper on 2008-001469-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001469-28.